Who Paid My Doc
Gail Mick
Pediatric Endocrinology Birmingham, AL Medical Doctor
NPI 1306959523 CMS profile 399874
1600 7Th Ave S, Birmingham, AL 35233
General payments
$136
Research payments
$68,278
Ownership & investment interest
$0
Research they led as principal investigator
$323,811
Through program year 2025, Gail Mick of Birmingham, AL is reported in the CMS Open Payments database as having received $136 across 8 general payments and $68,278 in research payments paid to them. Separately, studies naming them as principal investigator received $323,811 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 93rd percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | Research | $1,583 | 1 | |
| 2024 | General | $25 | 1 | |
| 2024 | Research | $15,720 | 3 | |
| 2023 | Research | $50,864 | 7 | |
| 2022 | General | $43 | 2 | |
| 2021 | General | $17 | 1 | |
| 2021 | Research | $111 | 1 | |
| 2020 | General | $28 | 2 | |
| 2019 | General | $24 | 2 |
Beside peers
- Gail Mick
- Pediatric Endocrinology median
- Middle half of Pediatric Endocrinology
- National median
In program year 2025, general payments to Gail Mick were reported at $0. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.
Show as a table
| Year | Gail Mick | Pediatric Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $24 | $196 | $68–$845 | $163 |
| 2020 | $28 | $124 | $37–$722 | $114 |
| 2021 | $17 | $134 | $35–$691 | $132 |
| 2022 | $43 | $177 | $47–$726 | $149 |
| 2023 | $0 | $236 | $75–$887 | $160 |
| 2024 | $25 | $259 | $91–$979 | $164 |
| 2025 | $0 | $293 | $106–$1,640 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
20 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Endocrinology in Alabama
Ambika Ashraf
Pediatric Endocrinology · Birmingham, AL
Chelsea Zimmerman
Pediatric Endocrinology · Opelika, AL
Anne Marie Kaulfers
Pediatric Endocrinology · Mobile, AL
Mary Scott
Pediatric Endocrinology · Birmingham, AL
Whei Ying Lim
Pediatric Endocrinology · Mobile, AL
Eliana Perez Garcia
Pediatric Endocrinology · Mobile, AL
Related records
Pediatric Endocrinology in Alabama
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in Alabama
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.